newsfilter
← Latest News
PR Newswire·

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the third quarter ended September 30, 2025. "We are pleased with...